Global Opioid Use Disorder Market Size, Share, Growth Trends, and Forecasts 2032

Opioid Use Disorder Market

Opioid Use Disorder Market By Drug (Buprenorphine, Methadone, and Naltrexone), By Route Of Administration (Oral Administration, Injectable Administration, and Others), By Distribution Channel (Hospital & Pharmacies, Retail Pharmacies, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 230 Report Code: ZMR-5103 Published Date: Sep-2026 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.10 Billion USD 7.65 Billion 10.58% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Opioid Use Disorder Market, 2024 - 2032, (USD Billion)
    • 2.2. Opioid Use Disorder Market: Snapshot
  • Chapter 3. Global Opioid Use Disorder Market - Industry Analysis
    • 3.1. Opioid Use Disorder Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rising opioid use
    • 3.3. Restraints
      • 3.3.1. Regulatory stringency
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Drug Segment
      • 3.6.2. Market attractiveness analysis by regional segment
  • Chapter 4. Global Opioid Use Disorder Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Opioid Use Disorder market: company market share analysis, 2024
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Opioid Use Disorder Market - Product Segment Analysis
    • 5.1. Global Opioid Use Disorder market overview: by Product
      • 5.1.1. Global Opioid Use Disorder market revenue share, by Product, 2024 and 2032
    • 5.2. Buprenorphine
      • 5.2.1. Global Opioid Use Disorder market by Buprenorphine, 2024-2032 (USD Billion)
      • 5.2.2. Bunavail
        • 5.2.2.1. Global Opioid Use Disorder market by Bunavail, 2024-2032 (USD Billion)
      • 5.2.3. Sublocade
        • 5.2.3.1. Global Opioid Use Disorder market by Sublocade, 2024-2032 (USD Billion)
      • 5.2.4. Suboxone
        • 5.2.4.1. Global Opioid Use Disorder market by Suboxone, 2024-2032 (USD Billion)
      • 5.2.5. Zubsolv
        • 5.2.5.1. Global Opioid Use Disorder market by Zubsolv, 2024-2032 (USD Billion)
      • 5.2.6. Others
        • 5.2.6.1. Global Opioid Use Disorder market by Others, 2024-2032 (USD Billion)
    • 5.3. Methadone
      • 5.3.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2024-2032 (USD Billion)
    • 5.4. Naltrexone
      • 5.4.1. Global Opioid Use Disorder market by Sleep monitoring devices, 2024-2032 (USD Billion)
  • Chapter 6. Global Opioid Use Disorder Market - Regional Analysis
    • 6.1. Global Opioid Use Disorder market overview: by region
      • 6.1.1. Global Opioid Use Disorder market revenue share, by region, 2024 and 2032
    • 6.2. North America
      • 6.2.1. North America Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
      • 6.2.2. North America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S. Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.3. Europe
      • 6.3.1. Europe Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
      • 6.3.2. Europe Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.3.3. U.K.
        • 6.3.3.1. U.K. Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.3.4. France
        • 6.3.4.1. France Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.3.5. Germany
        • 6.3.5.1. Germany Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of Europe Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
      • 6.4.2. Asia Pacific Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.4.3. China
        • 6.4.3.1. China Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.4.5. India
        • 6.4.5.1. India Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.5. Latin America
      • 6.5.1. Latin America Opioid Use Disorder market, by country, 2024-2032 (USD Billion)
      • 6.5.2. Latin America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
      • 6.5.4. Rest of Latin America
        • 6.5.4.1. Rest of Latin America Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
    • 6.6. Middle East & Africa
      • 6.6.1. Middle East & Africa Opioid Use Disorder market, 2024-2032 (USD Billion)
      • 6.6.2. Middle East & Africa Opioid Use Disorder market revenue, by Drug, 2024-2032 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Autonomic Technologies (ATI)
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Baxter Healthcare Corporation
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Bionano Genomics
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Compumedics Limited
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Infraredx, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Developments
    • 7.6. Inovio, Pharmaceuticals
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Developments
    • 7.7. Masimo Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Developments
    • 7.8. Neovasc Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Developments
    • 7.9. Nihon Kohden Corporation, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Opioid Use Disorder market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: Opioid Use Disorder market
5. Global Opioid Use Disorder market attractiveness, by Product
6. Global Opioid Use Disorder market attractiveness, by End user
7. Global Opioid Use Disorder market revenue share, by Product, 2024 and 2032
8. Global Opioid Use Disorder market revenue share, by End user, 2024 and 2032
9. Global Opioid Use Disorder market revenue share, by region, 2024 & 2032
10. North America Opioid Use Disorder market, 2024-2032 (USD Billion)
11. Europe Opioid Use Disorder market, 2024-2032 (USD Billion)
12. Asia Pacific Opioid Use Disorder market, 2024-2032 (USD Billion)
13. Latin America Opioid Use Disorder market, 2024-2032 (USD Billion)
14. Middle East & Africa Opioid Use Disorder market, 2024-2032 (USD Billion)
 


Table Of Tables

List of Tables

1. Global Opioid Use Disorder market: snapshot
2. Drivers for Opioid Use Disorder market: impact analysis
3. Restraints for Opioid Use Disorder market: impact analysis
4. North America Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
5. North America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
6. North America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
7. The U.S. Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
8. The U.S. Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
9. Rest of North America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
10. Rest of North America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
11. Europe Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
12. Europe Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
13. Europe Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
14. U.K. Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
15. U.K. Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
16. France Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
17. France Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
18. Germany Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
19. Germany Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
20. Rest of Europe Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
21. Rest of Europe Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
22. Asia Pacific Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
23. Asia Pacific Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
24. Asia Pacific Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
25. China Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
26. China Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
27. Japan Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
28. Japan Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
29. India Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
30. India Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
31. Rest of Asia Pacific Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
32. Rest of Asia Pacific Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
33. Latin America Opioid Use Disorder market revenue, by country, 2024-2032 (USD Billion)
34. Latin America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
35. Latin America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
36. Brazil Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
37. Brazil Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
38. Rest of Latin America Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
39. Rest of Latin America Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
40. Middle  East & Africa Opioid Use Disorder market revenue, by Product, 2024-2032 (USD Billion)
41. Middle  East & Africa Opioid Use Disorder market revenue, by End user, 2024-2032 (USD Billion)
 
 

Methodology

FrequentlyAsked Questions

Opioid use disorder is a medical illness that is characterized by a problematic habit of taking opioid medicines. These drugs include painkillers that are prescribed as well as illicit opioids such as heroin. It entails a loss of control over opioid usage, cravings, and negative repercussions such as concerns with one's health and social life.

The rising number of patients with opioid-related addiction, increased government efforts and increased support from NGOs and agencies are key factors driving the market for opioid use disorder care.

According to the report, the global opioid use disorder market size was valued at approximately USD 3.10 billion in 2023 and is projected to reach around USD 7.65 billion by 2032.

The global opioid use disorder market is expected to grow at a compound annual growth rate (CAGR) of around 10.58% during the forecast period from 2024 to 2032.

North America is expected to continue dominating the opioid use disorder market, accounting for the largest share due to high prevalence and established treatment infrastructure.

Key players in the global opioid use disorder market include Indivior PLC, Teva Pharmaceutical Industries, Ltd., Pfizer, Inc., Collegium Pharmaceutical (BioDelivery Sciences International, Inc.), Alkermes, Inc., Orexo US, Inc. (a part of Orexo AB), Titan Pharmaceuticals, Inc., Omeros Corporation, Camurus AB, and Hikma Pharmaceuticals PLC, among others.

The report provides a comprehensive analysis of market size, growth drivers, restraints, opportunities, segmentation by drug, route of administration, and distribution channel, regional insights, competitive landscape, and forecasts through 2032.

HappyClients